7 Result(s)

Article

Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasis

Despite improvement in the overall survival of patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation, the effects of EGFR tyrosine kinase inhibitor (EGFR-T...

Michihito Miyagi, Hirohisa Katagiri, Hideki Murata, Junji Wasa… in BMC Pulmonary Medicine (2022)

Article

Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non‑small cell lung cancer

Ari Nishimura, Akira Ono, Kazushige Wakuda, Takanori Kawabata… in Investigational New Drugs (2022)

Article

Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer

Background. Prognostic data on Japanese patients receiving durvalumab after chemoradiotherapy (CRT) for locally advanced non-small cell lung cancer (LA-NSCLC) are insufficient. Whether pneumonitis has prognostic ...

Ari Nishimura, Akira Ono, Kazushige Wakuda, Takanori Kawabata… in Investigational New Drugs (2022)

Article

Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients

The safety and effectiveness of neoadjuvant fractionated stereotactic radiotherapy (FSRT) before piecemeal resection of brain metastasis (BM) remains unknown.

Shoichi Deguchi, Koichi Mitsuya… in International Journal of Clinical Oncology (2022)

Article

Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer

Corrections are needed to the original version of this article. In Table 2, the “Odds ratio” of the variables “Lower lobe vs. Upper lobe” and “≥26 vs. <26” should be 2.250 instead of 2250 and 2.250 instead of ...

Hiroto Inoue, Akira Ono, Takanori Kawabata, Nobuaki Mamesaya… in Investigational New Drugs (2021)

Article

Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer

Introduction Durvalumab has been shown to confer a survival benefit after definitive chemoradiotherapy in the patients with locally advanced non-small cell lung cancer, but no studies have attempted to identify r...

Hiroto Inoue, Akira Ono, Takanori Kawabata, Nobuaki Mamesaya… in Investigational New Drugs (2020)

Article

Metastatic skull tumors: MRI features and a new conventional classification

Skull metastases are malignant bone tumors which are increasing in incidence. The objectives of this study were to characterize the MR imaging features, locations, and extent of metastatic skull tumors to dete...

Koichi Mitsuya, Yoko Nakasu, Satoshi Horiguchi… in Journal of Neuro-Oncology (2011)